<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7203261\results\search\drug\results.xml">
  <result pre="treatment of HIV in combination with a low dose of" exact="ritonavir" post="to increase its plasma half-life, has been used to"/>
  <result pre="11]. However, despite the use of lopinavir/ritonavir in combination with" exact="ribavirin" post="was initially considered a promising therapy for treating COVID-19"/>
  <result pre="Pneumonia [14] included as useful therapy, together with the antimalarial" exact="chloroquine" post="and the antiviral treatment for influenza arbidol, the broad-spectrum"/>
  <result pre="for its undesiderable side effect like anemia, the use of" exact="ribavirin" post="may not be convenient in patients who are already"/>
  <result pre="performed on 20 COVID-19 patients shows that the use of" exact="hydroxychloroquine" post="also by adding the antibacterial drug azithromycin is efficient"/>
  <result pre="the use of hydroxychloroquine also by adding the antibacterial drug" exact="azithromycin" post="is efficient in viral load reduction/disappearance [16]. Hydroxychloroquine and"/>
  <result pre="antibacterial drug azithromycin is efficient in viral load reduction/disappearance [16]." exact="Hydroxychloroquine" post="and chloroquine's antiviral activity appears to be due to"/>
  <result pre="report on the use of a combination of hydroxicloroquine and" exact="azithromycin" post="to treat COVID-19 patients showed no evidence of a"/>
  <result pre="development of type II transmembrane serine protease (TMPRSS2) inhibitors like" exact="camostat" post="mesilate, approved in Japan for the treatment of pancreatic"/>
  <result pre="safer therapies is humanity's ultimateÃ‚ challenge in the twenty-first century." exact="Today" post="we really had proof of this. Publisher's Note Springer"/>
  <result pre="2019-nCoV therapy registered in ChinaJ Med Virol20209254054510.1002/jmv.25733 16.GautretPLagierJCParolaPet al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="chloroquineLancet Infect Dis200662676910.1016/S1473-3099(06)70361-916439323 18.DevauxCARolainJMColsonPRaoultDNew insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19?Int J Antimicrob"/>
  <result pre="rapid antiviral clearance or clinical benefit with the combination of" exact="hydroxychloroquine" post="and azithromycin in patients with severe COVID-19 infectionMed Mal"/>
  <result pre="clearance or clinical benefit with the combination of hydroxychloroquine and" exact="azithromycin" post="in patients with severe COVID-19 infectionMed Mal Infect202010.1016/j.medmal.2020.03.00632240719 22.CalyLDruceJDCattonMGJansDAWagstaffKMThe"/>
  <result pre="patients with severe COVID-19 infectionMed Mal Infect202010.1016/j.medmal.2020.03.00632240719 22.CalyLDruceJDCattonMGJansDAWagstaffKMThe FDA-approved drug" exact="ivermectin" post="inhibits the replication of SARS-CoV-2 in vitroAntivir Res202010.1016/j.antiviral.2020.10478732251768 23.https://clinicaltrials.gov/ct2/show/NCT04304053?term=cobicistat&amp;amp;cond=covid-19&amp;amp;phase=2&amp;amp;draw=2&amp;amp;rank=1."/>
 </snippets>
</snippetsTree>
